Michael Heathman, M.S.

Group Leader, Principal Scientist II

Michael brings over 30 years of experience in the pharmaceutical industry.  Prior to joining Metrum Research Group in 2018, he was Head of Global Pharmacometrics at Eli Lilly and Company, where he led efforts to apply PK/PD modeling and simulation to all phases of drug development.  He has extensive experience in the application of pharmacometrics to support quantitative decision making across a broad range of disease states and therapeutic areas.